Aatinski, J.T., et al., “A Coupled One-Step Reverse Transcription PCR Procedure For Generation of Full-Length Open Reading Frames,” BioTechniques, 16:282-288 (1994). |
Abbotts, J., et al., “Mechanism of HIV-1 Reverse Transcriptase,” J. Biol. Chem. 268:10312-10323 (May 1993). |
Alexander, F., et al., “Proteolytic Processing of Avian Sarcoma and Leukosis Viruses pol-endo Recombinant Proteins Reveals Another pol Gene Domain,” J. Virol. 61:534-542 (Feb. 1987). |
Anderson, D., et al., “Rapid Generation of Recombinant Baculovirus and Expression of Foreign Genes Using the BAC-TO-BAC™ Baculovirus Expression System,” Focus 17:53-58 (1995). |
Barnes, W.M., “The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion,” Gene 112:29-35 (1992). |
Barr, P.J., et al., “Expression of Active Human Immunodeficiency Virus Reverse Transcriptase in Saccharmyces cerevisiae,” BioTechnology 5:486-489 (May 1987). |
Berger, S.L., et al., “Reverse Transcriptase and Its Associated Ribonuclease H: Interplay Two Enzyme Activities Controls the Yield of Single-Stranded Complementary Deoxyribonucleic Acid,” Biochemistry 22:2365-2372 (1983). |
Chattopadhyay, D., et al., “Purification and Characterization of Heterodimeric Human Immudeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Produced by in Vitro Processing of p66 with Recombinant HIV-1 Protease,” J. Biol. Chem. 267:14227-14232 (Jul. 1992). |
Chernov, A.P., et al., “Recombinant Reverse Transcriptase of Rous Sarcoma Virus: Characterization of DNA Polymerase and RNAase H activities,” Biomed. Sci. 2:49-53 (1991). |
Dudding, L.R., et al., “Analysis of the RNA- and DNA-dependent DNA Polymerase Activities of Point Mutants of HIV-1 Reverse Transcriptase Lacking Ribonuclease H Activity,” Biochemistry 30:10498-10506 (1991). |
Freeman, W.M., et al., “Use of Elevated Reverse Transcription Reaction Temperature in RT-PCR,” BioTechniques 20:782-783 (May 1996). |
Flaman, J.M., et al., “A Rapid PCR Fidelity Assay,” Nucl. Acids Res. 22:3259-3260 (Aug. 1994). |
Gerard, G.F., et al., “Poly(2′-O-methylcytidylate) Oligodeoxyguanylate as a Template for the Ribonucleic Acid Directed Deoxyribonucleic Acid Polymerase in Ribonucleic Acid Tumor Virus Particles and a Specific Probe for the Ribonucleic Acid Directed Enzyme in Transformed Murine Cells,” Biochemistry 13:1632-1641 (Apr. 1974). |
Gerard, G.F., et al., “cDNA Synthesis by Clone Moloney Murine Leukemia Virus Reverse Transcriptase Lacking RNase H Activity,” Focus 11:66-69 (1989). |
Gerard, G.F. et al., “cDNA Synthesis by Moloney Murine Leukemia Virus Rnase H-Minus Reverse Transcriptase Possessing Full DNA Polymerase Activity,” Focus 14:91-93 (1992). |
Gerard, G.F., “Reverse Transcriptase: A Historical Perspective,” Focus 20(3):65-67 (Fall 1998). |
Grandgenett, D.P., et al., “A Single Subunit from Avian Myeloblastosis Virus with Both RNA-Directed DNA Polymerase and Ribonuclease H Activity,” Proc. Natl. Acad. Sci. USA 70:230-234 (Jan. 1973). |
Grandgenett, D.P., et al., “Large-Scale Purification of Ribonucleic Acid Tumor Viruses by Use of Continuous-Flow Density Gradient Centrifugation,” Appl. Microbiol. 26:452-454 (Sep. 1973). |
Gubler, U., and Hoffman, B.J., “A Simple and Very Efficient Method for Generating cDNA Libraries,” Gene 25:263-26 (Nov. 1983). |
Hizi, A., and Joklik, W.K., et al., “RNA-dependent DNA Polymerase of Avian Sarcoma Virus B77,” J. Biol. Chem. 252:2218-2289 (Apr. 1977). |
Hizi, A., et al., “Mutational Analysis of the Ribonuclease H Activity of Human Immunodeficiency Virus 1 Reverse Transcriptase,” Virol. 175:575-580 (1990). |
Hostomsky, Z., et al., “Reverse Transcriptase of Human Immunodeficiency Virus Type 1:Functionality of Subunits of the Heterodimer in DNA Synthesis,” J. Virol. 66:3179-3182 (May 1992). |
Houts, G.E., et al., “Reverse Transcriptase from Avian Myeloblastosis Virus,” J. Virol. 29:517-522 (Feb. 1979). |
Huber, H.E., et al., “Human Immunodeficiency Virus 1 Reverse Transcriptase,” J. Biol. Chem. 264:4469-4678 (Mar. 1989). |
Johnson, M.S., et al., “Computer analysis of retroviral pol genes: Assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes,” Proc. Natl. Acad. Sci. USA 83:7648-7652 (Oct. 1986). |
Kanaya, S., et al., “Identification of the Amino Acid Residues Involved in an Active Site of Escerichia coli Ribonuclease H by Site-directed Mutagenesis,” J. Biol. Chem. 265:4615-4621. |
Kawa, S., et al., “Expression and Purification of the HIV-1 Reverse Transcriptase Using the Baculovirus Expression Vector System,” Prot. Exp. Purif. 4:298-303 (Aug. 1993). |
Knapp, B., et al., “In vitro translation of Plasmodium falciparum aldolase is not initiated at an unusual site,” EMBO J. 10:3095-3097 (Oct. 1991). |
Kokko, H.I., et al., “Single-Step Immunocapture RT-PCR in the Detection of Raspberry Bushy Dwarf Virus,” BioTechniques 20:842-846 (May 1996). |
Kotewicz, M.L., et al., “Isolation of Cloned Maloney Murine Leukemia Virus Reverse Transcriptase Lacking Ribonuclease H Activity,” Nucl. Acids Res. 16:265-277 (1988). |
Krug, M.S., et al., “First-Strand cDNA Synthesis Primed with Obligo(dT),” Meth. Enzymol. 152:316-325 (1987). |
Lawyer, F.C., et al., “High-Level Expression, Purification, and Enzymatic Characterization of Full-Length Thermus aquaticus DNA Polymerase and a Trancated Form Deficient in 5′ to 3′ Exonuclease Activity,” PCR Meth. Appl. 2:275-287 (May 1993). |
Lee, E.H., et al., “A Highly Sensitive Method for One-Step Amplification of RNA by Polymeraase Chain Raction,” Focus 19:39-42 (Spring 1997). |
Le Grice, S.F.J., and Grüninger-Leitch, F., “Rapid Purification of Homodimer and Heterodimer HIV-1 Reverse Transcriptase by Metal Chelate Affinity Chromatography,” Eur. J. Biochem. 187:307-314 (Jan. 1990). |
Le Grice, S.F.J., “Human Immonodeficiency Virus Reverse Transcriptase,” in Reverse Transcriptase, Shalka, A.M., and Goff, S.P., Eds., Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 163-191 (1993). |
Lowe, D.M., et al., “HIV-1 Reverse Transcriptase: Crystallization and Analsysi of Domain Structure by Limited Proteolysis,” Biochemistry 27:8884-8889 (Dec. 1988). |
Mallet, F., et al., “Continuous RT-PCR using AMV-RT and Taq DNA Polymerase: Characterization and Comparison to Uncoupled Procedures,” BioTechniques 18:678-687 (Apr. 1995). |
Messer, L.I., et al., “Functional Analysis of Reverse Transcription by a Frameshift pol Mutant of Murine Leukemia Virus,” Virology 146:146-152 (1985). |
Mizrahhi, V., et al., “Recombinant HIV-1 Reverse Transcriptase: Purification, Primary Structure, and Polymerase/Ribonuclease H activities,” Arch. Biochem. Biophys, 273:347-358 (Sep. 1989). |
Mizrahi, V., et al., “Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase,” Nucl. Acids Res. 18:5359-5363 (Sep. 1990). |
Müller, B., et al., “Co-expression of the Subunits of the Heterodimer of HIV-1 Reverse Transcriptase in Escherichia coli,” J. Biol. Chem. 264:13975-13978 (Aug. 1989). |
Myers, T.W., and Gelfand, D.H., “Reverse Transcription and DNA Amplification by a Thermus thermophillus DNA Polymerase,” Biochemistry 30:7661-7666 (Aug. 1991). |
Prasad, V.R., et al., “Genetic Analysis of Retroviral Reverse Transcriptase Structure and Function,” in Reverse Transcriptase, Skalka, A.M., and Goff, S.P., Eds., Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 135-162 (1993). |
Repaske, R., et al., “Inhibition of Rnase H Activity and Viral Replication by Single Mutations in the 3′ Region of Moloney Murine Leukemia Virus Reverse Transcriptase,” J. Virol. 63:1460-1464 (Mar. 1993). |
Saiki, R.K., et al., “Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymease,” Science 239:487-491 (Jan. 1988). |
Sambrook, J., et al., “Protocol for the Synthesis of the First Strand of cDNA,” in Molecular Cloning: A Laboratory Manual 2nd Edition, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 8.60-8.63 (1989). |
Schwartz, D.E., et al., “Nucleotide Sequence of Rouse Sarcoma Virus,” Cell 32:853-869 (Mar. 1983). |
Sellner, L.N., et al., “Reverse transcriptase inhibits Taq Polymerase Activity,” Nucl. Acids Res. 20:1487-1490 (1992). |
Sitaraman, K., et al., “RT-PCR of Difficult Templates Using the Superscript One-Step™ RT-PCR System,” Focus 19:43-44 (Spring 1997). |
Skalka, A.M., et al., “Endonuclease Activity Associated with Reverse Transcriptase of Avian Sarcoma-Leukosis Viruses,” in Reverse Transcriptase, Skalka, A.M., and Goff, S.P., Eds., Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 193-204 (1993). |
Soltis, D.A., and Skalka, A.M., “The α and β chains of avian retrovirus reverse transcriptase independently expressed in Escherichia coli: Characterization of Enzymatic Activities,” Proc. Natl. Acad. Sci. USA 85:3372-3376 (May 1988). |
Stahlhut, M., et al., “Purification and Characterization of HIV-1 Reverse Transcriptase Having a 1:1 Ratio of p66 and P51 Subunits,” Prot. Exp. Purif. 5:614-621 (Dec. 1994). |
Strauss, E.M., et al., “Efficient Production of Mammalian RNA Tumor Viruses in Serum-Free Culture Medium Allows Rapid RNA Subunit Purification,” J. Virol. Meth. 1:213-221 (1980). |
Telesnitsky, A., and Goff, S.P., “RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template,” Proc. Natl. Acad. Sci. USA 90:1276-1280 (Feb. 1993). |
Wang R.F., et al., “A Simplified, Single Tube, Single Buffer System for RNA-PCR,” BioTechniques 12:702,704 (May 1992). |
Weaver, D.T., and DePamphilis, M.L., “Specific Sequences in Native DNA that Arrest Synthesis by DNA Polymerase α,” J. Biol. Chem. 257:2075-2086 (Feb. 1982). |
Boehringer Mannheim Biochemicals, “Reverse Transcriptase AMV,” “Reverse Transcriptase M-MuLV,” Reverse Transcriptase, HIV-1, Products Catalogue, pp. 92-93, (1995). |
Life Technologies, Inc., “GIBOC BRL Baculovirus Expression Products,” Product Technical Literature (1996). |
Toyobo, Tokyo, Japan, “M-MLV Reverse Transcriptase (Rnase H-) ReverTraAce,” Product Literature (1998). |
Schwabe, W., et al., “ThermoScript™ RT, a New Avian Reverse Transcriptase for High-Temperature cDNA Synthesis to Improve RT-PCR,” Focus 20:30-33 (Spring 1998). |
Dialog File 351, Accession No. 1995-129461/199517, Derwent WPI English language abstract for SU 1490961. |
Champoux, J.J., “Roles of Ribonuclease H in Reverse Transcription,” in: Reverse Transcriptase, A.M. Skalka and S.P. Goff, eds., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 103-117 (1993). |
Chattopadhyay, D., et al., “Resolution of Microheterogeneity Associated with Recombinant HIV-1 Heterodimeric Reverse Transcriptase,” Prot. Exp. Purif. 3:151-159, Academic Press, Inc., New York, NY (1992). |
Chernov, A.P., et al., “Recombinant RNA-dependent DNA-Polymerase RSV: Isolation and General Properties,” Biokhimiia (USSR) 55:586-594 Academy of Sciences of the USSR, Moscow, USSR (1990). |
Dialog File 155 (Medline), Accession No. 90335319, English-language abstract for Chernov et al. (Doc. No. AR22). |
Gerard, G.F., “Synthesis of High Specific Activity cDNA,” Focus 10(1):12-13, Life Technologies, Inc., Gaithersburg, MD (1988). |
Hizi, A., and Joklik, W.K., “RNA-dependent DNA Polymerase of Avian Sarcoma Virus B77,” J. Biol. Chem. 252:2281-2289, American Society of Biological Chemists, Inc., Washington, DC (1977). |
Myers, J.C., and Spiegelman, S., “Sodium pyrophosphate inhibition of RNA-DNA hybrid degradation by reverse transcriptase,” Proc. Natl. Acad. Sci. USA 75:5329-5333, National Academy of Sciences of the U.S.A., Washington, DC (1978). |
Nathan, M., et al., “Optimizing Long PCR,” Focus 17(3): 78-80, Life Technologies, Inc., Gaithersburg, MD (1995). |
Stewart, L., and Vogt, V.M., “Reverse Transcriptase and Protease Activities of Avian Leukosis Virus Gag-Pol Fusion Proteins Expressed in Insect Cells,” J. Virol. 67:7582-7596, American Society for Microbiology, Washington, DC (1995). |
Verma, I.M., “Studies on Reverse Transcriptase of RNA Tumor Viruses. III. Properties of Purified Moloney Murine Leukemia Virus DNA Polymerase and Associated RNase H,” J. Virol. 15:843-854, American Society for Microbiology, Washington, DC (1975). |
Wang, L.-H., and Duesberg, P.H., “DNA Polymerase of Murine Sarcoma-Leukemia Virus: Lack of Detectable RNase H and Low Activity With Viral RNA and Natural DNA Templates,” J. Virol. 12:1512-1521, American Society for Microbiology, Washington, DC (1973). |
Werner, S., and Wöhrl, B.M., “Soluble Rous Sarcoma Virus Reverse Transcriptase α, αβ, and β Purified from Insect Cells Are Processive DNA Polymerases That Lack and RNase H3′-5′ Directed Processing Activity,” J. Biol. Chem. 274:26329-26336, American Society for Biochemistry and Molecular Biology, Inc., Washington, DC (Sep. 1999). |
Yu, H., and Goodman, M.F., “Comparison of HIV-1 and Avian Myeloblastosis Virus Reverse Transcriptase Fidelity on RNA and DNA Templates,” J. Biol. Chem. 267:10888-10896, American Society for Biochemistry and Molecular Biology, Inc., Washington, DC (1992). |
Life Tecnologies, Inc., Rockville, MD, “Instruction Manual for GIBCO/BRL® Superscript™ First-Strand Synthesis System for RT-PCR (Cat No. 11904-018)” (1999). |
Life Tecnologies, Inc., Rockville, MD, “Instruction Manual for GIBCO/BRL® Superscript™ Preamplification System for First-Strand cDNA Synthesis (Cat. No. 18089-011)” (1999). |
Dialog File 351 (Derwent World Patents Index), English-language abstract for JPO Publication No. 7-39378 A (Doc. No. AM2), WPI Accession No. 1995-117859/199516. |
National Institutes of Health, National Library of Medicine/NCBI, NCBI sequence lisitng for JPO Publication No. 7-39378 A (Doc. No. AM2), obtained from Internet at <<http://www.ncbi.nlm.nih.gov/entrez/viewer.cgi>>, Accession No. E08693 (downloaded on Feb. 6, 2001). |
Allain, B. et al., “CIS Elements and Trans-acting Factors required for Minus Strand DNA Transfer during Reverse Transcription of the Genomic RNA of Murine Leukemia Virus,” J. Mol. Biol. 277:225-235, Academic Press Limited (Mar. 1998). |
Arion, D. et al., “The K65R Mutation Confers Increased DNA Polymerase Processivity to HIV-1 Reverse Transcriptase,” J. Biol. Chem. 271:19860-19864, The American Society for Biochemistry and Molecular Biology, Inc. (1996). |
Arnold, E. et al., “Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations,” Nature 357:85-89, Macmillan Publishers Ltd. (1992). |
Bahar, I., “Collective Motions in HIV-1 Reverse Transcriptase: Examination of Flexibility and Enzyme Function,” J. Mol. Biol. 285:1023-1037, Academic Press (Jan. 1999). |
Basu, S. et al., “Sulphydryl groups in the template-primer-binding domain of murine leukaemia virus reverse transcriptase,” Biochem. J. 296:577-583, The Biochemical Society (1993). |
Beard, W.A. et al., “Structure/Function Studies of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” J. Biol. Chem. 269:28091-28097, American Society for Biochemistry and Molecular Biology (1994). |
Ben-Artzi, H. et al., “Characterization of the double stranded RNA dependent RNAse activity associated with recombinant reverse transcriptases,” Nucl. Acids Res. 20:5115-5118, Oxford University Press (1992). |
Blain, S.W. and Goff, S.P., “Effects on DNA Synthesis and Translocation Caused by Mutations in the RNase H Domain of Moloney Murine Leukemia Virus Reverse Transcriptase,” J. Virol. 69:4440-4452, American Society for Microbiology (1995). |
Blain, S.W. and Goff, S.P., “Differential Effects of Moloney Murine Leukemia Virus Reverse Transcriptase Mutations on RNase H Activity in Mg2+ and Mn2+,” J. Biol. Chem. 271:1448-1454, The American Society for Biochemistry and Molecular Biology, Inc. (1996). |
Carl, P.L. et al., “Isolation and Mapping of a Mutation in Escherichia coli with Altered Levels of Ribonuclease H,” J. Bacteriol. 144:28-35, American Society for Microbiology (1980). |
Chowdhury, K. et al., “Elucidation of the Role of Arg 110 of Murine Leukemia Virus Reverse Transcriptase in the Catalytic Mechanism: Biochemical Characterization of Its Mutant Enzymes,” Biochemistry 35:16610-16620, American Chemical Society (1996). |
DeStefano, J.J. et al., “Requirements for Strand Transfer between Internal Regions of Heteropolymer Templates by Human Immunodeficiency Virus Reverse Transcriptase,” J. Virol. 66:6370-6378, American Society for Microbiology (1992). |
Diaz, L. and DeStefano, J.J., “Strand transfer is enhanced by mismatched nucleotides at the 3′ primer terminus: a possible link betwen HIV reverse transcriptase fidelity and recombination,” Nucl. Acids Res. 24:3086-3092, Oxford University Press (1996). |
Drosopoulos, W.C. and Prasad, V.R., “Increased Polymerase Fidelity of E89G, a Nucleoside Analog-Resistant Variant of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” J. Virol. 70:4834-4838, American Society for Microbiology (1996). |
Feng, J.Y. and Anderson, K.S., “Mechanistic Studies Examining the Efficiency and Fidelity of DNA Synthesis by the 3TC-Resistant Mutant (184V) of HIV-1 Reverse Transcriptase,” Biochemistry 38:9440-9448, American Chemical Society (Jul. 1999; published on the web Jun. 30, 1999). |
Gao, G. et al., “Conferring RNA polymerase Activity to a DNA polymerase: A single residue in reverse transcriptase controls substrate selection,” Proc. Natl. Acad. Sci (USA) 94:407-411, National Academy of Sciences (Jan. 1997). |
Gao, G. and Goff, S.P., “Replication Defect of Moloney Murine Leukemia Virus with a Mutant Reverse Transcriptase That Can Incorporate Ribonucleotides and Deoxyribonucleotides,” J. Virol. 72:5905-5911, American Society for Microbiology (Jul. 1988). |
Gao, H.-Q. et al., “Similarities and Differences in the RNase H Activites of Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Moloney Murine Leukemia Virus Reverse Transcriptase,” J. Mol. Biol. 294:1097-1113 (Dec. 1999). |
Georgiadis, M.M. et al., “Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase,” Structure 3:879-892, Current Biology Ltd. (1995). |
Gerard, G.F., “Multiple RNase H Activities in Mammalian Type C Retravirus Lysates,” J. Virol. 26:16-28, American Society Microbiology (1978). |
Gerard, G.F. and D'Alessio, J.M., “Reverse Transcriptase (EC 2.7.7.49): The Use of Cloned Moloney Murine Leukemia Virus Reverse Transcriptase to Synthesize DNA from RNA,” in Methods in Molecular Biology, vol. 16: Enzymes of Molecular Biology, Burrell, M.M., ed., Humana Press Inc., Totowa, N.J., pp. 73-93 (1993). |
Goedken, E.R. and Marqusee, S., “Folding the Ribonuclease H Domain of Moloney Murine Leukemia Virus Reverse Transcriptase Requires Metal Binding or a Short N-Teminal Extension,” Proteins: Structure, Function, and Genetics 33:135-143, Wiley-Liss, Inc. (Oct. 1998). |
Goff, S. et al., “Isolation and Properties of Moloney Murine Leukemia Virus Mutants: Use of a Rapid Assay for Release of Virion Reverse Transcriptase,” J. Virol. 38:239-248, American Society for Microbiology (1981). |
Goff, S.P., “Retroviral Reverse Transcriptase: Synthesis, Structure, and Function,” J. Acquired Immune Deficiency Syndromes 3:817-831, Raven Press, Ltd. (1990). |
Goobar-Larsson, L. et al., “Disruption of a Salt Bridge between Asp 488 and Lys 465 in HIV-1 Reverse Transcriptase Alters Its Proteolytic Processing and Polymerase Activity,” Virology 196:731-738, Academic Press, Inc. (1993). |
Gopalakrishnan, V. et al., “Human immunodeficiency virus type 1 reverse transcriptase: Spatial and temporal relationship between the polymerase and RNase H activities,” Proc. Natl. Acad. Sci. (USA) 89:10763-10767, National Academy of Sciences (1992). |
Guo, J. et al., “Defects in Primer-Template Binding, Processive DNA Synthesis, and RNase H Activity Associated with Chimeric Reverse Transcriptases Having the Murine Leukemia Virus Polymerase Domain Joined to Escherichia coli RNase H,” Biochemistry 34:5018-5029, American Chemical Society (1995). |
Jacobo-Molina, A. et al., “Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA,” Proc. Natl. Acad. Sci. (USA) 90:6320-6324, National Academy of Sciences (1993). |
Jaeger, J. et al., “The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor,” EMBO J. 17:4535-4542, Oxford University Press (Aug. 1998). |
Keck, J.L., et al., “Activation/Attenuation Model for RNase H. A One-Metal Mechanism with Second-Metal Inhibition,” J. Biol. Chem. 273:34128-34133, The American Society for Biochemistry and Molecular Biology, Inc. (Dec. 1998). |
Kelleher, C.D. and Champoux, J.J., “Characterization of RNA Strand Displacement Synthesis by Moloney Murine Leukemia Virus Reverse Transcriptase,” J. Biol. Chem. 273:9976-9986, The American Society for Biochemistry and Molecular Biology, Inc. (Apr. 1998). |
Kohlstaedt, L.A. et al., “Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor,” Science 256:1783-1790, American Association for the Advancement of Science (1992). |
Lavignon, M. et al., “Inhibition of Moloney Murine Leukemia Virus Reverse Transcriptase by α-Anomeric Oligonucleotides,” Biochem. Biophys. Res. Commun. 161:1184-1190, Academic Press, Inc. (1989). |
Levin, H.L., “An Unusual Mechanism of Self-Primed Reverse Transcription Requires the RNase H Domain of Reverse Transcriptase To Cleave and RNA Duplex,” Mol. Cell. Biol. 16:5645-5654, American Society for Microbiology (1996). |
Levin, H.L., “It's Prime Time for Reverse Transcriptase,” Cell 88:5-8, Cell Press (Jan. 1997). |
Loya, S. and Hizi, A., “The Interaction of Illimaquinone, a Selective Inhibitor of the RNase H Activity, with the Reverse Transcriptases of Human Immunodeficiency and Murine Leukemia Retroviruses,” J. Biol. Chem. 268:9323-9328, The American Society for Biochemistry and Molecular Biology, Inc. (1993). |
Misra, H.S. et al., “An Enzymatically Active Chimeric HIV-1 Reverse Transcriptase (RT) with the RNase-H Domain of Murine Leukemia Virus RT Exists as a Monomer,” J. Biol. Chem. 273:9785-9789, The American Society for Biochemistry and Molecular Biology, Inc. (Apr. 1998). |
Patel P.H. et al., “Insights into DNA Polymerization Mechanisms from Structure and Fucntion Analysis of HIV-1 Reverse Transcriptase,” Biochemistry 34:5351-5363, American Chemical Society (1995). |
Peliska, J. A. and Benkovic, S.J., “Mechanism of DNA Strand Transfer Reactions Catalyzed by HIV-1 Reverse Transcriptase,” Science 258:1112-1118, American Association for the Advancement of Science (1992). |
Post, K. et al., “A Large Deletion in the Connection Subdomain of Murine Leukemia Virus Reverse Transcriptase or Replacement of the RNase H Domain with Escherichia coli RNase H Results in Altered Polymerase and RNase H Activities,” Biochemistry 32:5508-5517, American Chemical Society (1993). |
Shirasawa, Y. et al., “Transdominant Inhibition of Moloney Murine Leukemia Virus Proliferation by Defective Mutants of Reverse Transcriptase,” J. Biochem. 119:1070-1075, The Japanese Biochemical Society (1996). |
Smith, C.M. et al, “Sequence Requirements for Removal of tRNA by an Isolated Human Immunodeficiency Virus Type 1 RNase H Domain,” J. Virol. 72:6805-6812, American Society for Microbiology (Aug. 1998). |
Spedding, G. et al., “Inhibition of reverse transcriptases by flavonoids,” Antiviral Res. 12:99-110, Elsevier Science Publishers B.V. (Biomedical Division) (1989). |
Sun, D. et al., “Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: Crystallization of nucleic acid complexes,” Protein Sci. 7:1575-1582, Cambridge University Press (Jul. 1998). |
Tanese, N et al., “Abortive Reverse Transcription by Mutants of Moloney Murine Leukemia Virus Deficient in the Reverse Transcriptase-Associated RNase H Function,” J. Virol. 65:4387-4397, American Society for Microbiology (1991). |
Trentin B. et al., “Human T-cell Leukemia Virus Type 1 Reverse Transcriptase (RT) Originates form the pro and pol Open Reading Frames and Requres the Presence of RT-RNase H (RH) and RT-RH-Integrase Proteins for its Activity,” J. Virol. 72:6504-6510, American Society for Microbiology (Aug. 1998). |
Veal, G.J. et al., “Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro,” Nucl. Acids Res. 26:5670-5675, Oxford University Press (Dec. 1998). |
Yadav, P.N.S. et al., “A Computer-assisted Analysis of Conserved Residues in the Three-dimensional Structures of the Polymerase Domains of Escherichia coli DNA Polymerase I and HIV-1 Reverse Transcriptase,” J. Biol. Chem. 269:716-720, The American Society for Biochemistry and Molecular Biology, Inc. (1994). |
Witing, S.H. and Champoux, J.J., “Properties of Strand Displacement Synthesis by Moloney Murine Leukemia Virus Reverse Transcriptase: Mechanistic Implications,” J. Mol. Biol. 278:559-577, Academic Press Limited (May 1998). |
Wilson, J.E. et al., “Human Immunodeficiency Virus Type-1 Reverse Transcriptase. Contribution of Met-184 to Binding of Nucleoside 5′-Triphosphate,” J. Biol. Chem. 271:13656-13662, The American Society for Biochemistry and Molecular Biology, Inc. (1996). |
Wöhrl, B.M. et al., “Footprint Analysis of Replicating Murine Leukemia Virus Reverse Transcriptase,” Science 267:96-99, The American Association for the Advancement of Science (1995). |
Co-Pending U.S. Patent Application No. 09/064,057, Gerard et al., filed Apr. 22, 1998. |
Co-Pending U.S. Patent Application No. 09/472,066, Lee and Rashtchian, filed Dec. 23, 1999. |
Co-Pending U.S. Patent Application No. 09/515,513, Li et al., filed Feb. 29, 2000. |
Co-Pending U.S. Patent Application No. 09/533,548, John A. Hughes Jr., filed Mar. 23, 2000. |
Co-Pending U.S. Patent Application No. 09/845,157, Smith et al., filed May 1, 2001. |
“Memorandum Opinion” and attached “Order” dated May 4, 2001 from Invitrogen Corporation v. Clontech Laboratories, Inc., U.S. District Court for the District of Maryland, Civil Action No. AW 96-4080. |
Aatsinki, J.T., “Coupled One-Step Reverse Transcription and Polymerase Chain Reaction Procedure for Cloning Large cDNA Fragments,” Meth. Mol. Biol. 67:55-60, White Humana Press, Inc. (Oct. 1996). |
Ando, T. et al., “A One-Tube Method of Reverse Transcription-PCR To Efficiently Amplify a 3-Kilobase Region from the RNA Polymerase Gene to the Poly(A) Tail of Small Round-Structured Viruses (Norwalk-Like Viruses,” J. Clin. Microb. 35:570-577, American Society for Microbiology (1997). |
Casas, I. et al., “Two Different PCR Assays to Detect Enteroviral RNA in CSF Samples From Patients With Acute Aseptic Meningitis,” J. Med. Virol. 47:378-385, Wiley-Liss, Inc. (1995). |
Freeman-Witting, M.-J. et al., “Differential Effects of Captan on DNA Polymerase and Ribonuclease H Activities of Avian Myeloblastosis Virus Reverse Transcriptase,” Biochemistry 25:3050-3055, American Chemical Society (1986). |
Goblet, C. et al., “One-step amplification of transcripts in total RNA using the polymerase chain reaction,” Nucl. Acids Res. 17:2144, IRL Press (1989). |
Moelling, K., “Further Characterization of the Friend Murine Leukemia Virus Reverse Transcriptase—RNase H Complex,” J. Virol. 18:418-425, American Society for Microbiology (1976). |
Payan, C. et al., “Detection of hepatitis C virus RNA by a reliable, optimized single-step reverse transcription polymerase chain reaction,” Res. Virol. 146:363-370, Elsevier (1995). |
“Enzymatic Amplification of RNA by PCR,” in: Current Protocols in Molecular Biology Supplement 17, Ausubel, F., et al., eds., John Wiley and Sons, Inc., New York, New York, pp. 15.4.1-15.4.4 (1992). |
Tosh, C., et al., “One-Tube and One-Buffer System of RT-PCR Amplification of 1D Gene of Foot-and-Mouth Disease Virus Field Isolates,” Acta Virol. 41:153-155, Slovak Academic Press (Jun. 1997). |